Yes big threat ..... LMAO
You will have to do a little better than that @Cato
Preparations for Phase 1 trial
18 June 2020 – Perth, Australia: PharmAust Ltd (ASXAA), a clinical-stage oncology company, is pleased to provide an update on its repeat cell culture preliminary experiments investigating the effects of monepantel (MPL) and monepantel sulfone (MPLS) upon cells infected with SARS-CoV-2 in cell culture. Replication of the in vitro virus infectivity experiment and using the same TCID50 method as that announced on 4 June 2020 confirmed initial findings. qPCR is quicker, cheaper and less labour intensive yet a less informative experiment than TCID50. It is used to check first whether TCID50 should be performed. Given both qPCR and TCID50 both showed monepantel antiviral
MSB Trading - 2020, page-14556
-
- There are more pages in this discussion • 8,605 more messages in this thread...
This thread is closed.
You may not reply to this discussion at this time.
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.25 |
Change
-0.055(4.21%) |
Mkt cap ! $1.432B | |||
| Open | High | Low | Value | Volume |
| $1.27 | $1.30 | $1.17 | $16.33M | 13.23M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 25192 | $1.25 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.26 | 40336 | 11 |
View Market Depth
| Last trade - 13.57pm 24/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |